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Background: Data sharing enables researchers to conduct novel 
research with previously collected data sets, thus maximising scientific 
findings and cost effectiveness, and reducing research waste. The 
value of sharing anonymised data from clinical trials is well recognised 
with a moderated access approach recommended. While substantial 
challenges to data sharing remain, there are additional challenges for 
qualitative data. Qualitative data including videos, interviews, and 
observations are often more readily identifiable than quantitative 
data. Existing guidance from UK Economic and Social Research 
Council applies to sharing qualitative data but does not address the 
additional challenges related to sharing qualitative data collected 
within trials, including the need to incorporate the necessary 
information and consent into already complex recruitment processes, 
with the additional sensitive nature of health-related data. 
Methods: Work package 1 will involve separate focus group 
interviews with members of each stakeholder group: trial managers, 
clinical trialists, qualitative researchers, members of research funding 
bodies and trial participants who have been involved in qualitative 
research. Data will be analysed using thematic analysis and managed 
within QSR NVivo to enhance transparency. Work package 2 will 
involve a documentary analysis of current consent procedures for 
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qualitative data collected as part of the conduct of clinical trials. We 
will include documents such as participant information leaflets and 
consent forms for the qualitative components in trials. We will extract 
data such as whether specific clauses for data sharing are included in 
the consent form. Content analysis will be used to analyse whether 
and how consent is being obtained for qualitative data sharing. 
Conclusions: This study will provide insight into the existing practice 
of sharing of qualitative data in clinical trials and the current issues 
and opportunities, to help shape future research and development of 
guidance to encourage maximum learning to be gained from this 
valuable data.
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Introduction
Data sharing enables researchers to conduct novel research 
with previously-collected data sets, thus maximising scien-
tific findings and cost effectiveness, and reducing research 
waste (DuBois et al., 2018). The value of sharing data in clini-
cal trials is well recognised, with a moderated (controlled) access 
approach recommended (Sydes et al., 2015), and guidelines exist 
for how this should be done (Keerie et al., 2018; Institute of 
Medicine, 2015; Ohmann et al., 2017). While substantial chal-
lenges to data sharing remain, there are additional challenges 
for qualitative data (NASEM, 2020). This is particularly 
evident in the context of general data protection regula-
tion (GDPR) in Europe and its implementation in the Data 
Protection Act (2018), where an individual’s right to the 
privacy of their personal data is paramount. There are specific 
challenges in sharing qualitative data, including videos, interviews, 
and observations, which are often more readily identifiable than 
quantitative data. Therefore, concerns for privacy become chal-
lenging, specifically regarding pseudonymisation which has been 
identified as a major barrier to data sharing (Aitken et al., 2016; 
Ruggiano & Perry, 2019). Pseudonymisation can be described 
a technique that replaces or removes information in a data set 
that identifies an individual (Mourby et al., 2018). Further-
more, while the public may assume or expect their quantitative 
data to be shared, they may not be clear or comfortable with 
sharing their qualitative data (Aitken et al., 2016).
It is well recognised that qualitative components of trials are 
valuable for: developing further research hypotheses; gathering 
complementary information to contribute to answering research 
questions in depth and helping to explain findings (Rapport 
et al., 2013). In addition, qualitative research in trials can be 
particularly helpful in developing and evaluating complex inter-
ventions as it provides valuable insights to issues experienced 
by potential participants (Rapport et al., 2013). However, there 
is little guidance on how to approach sharing this type of data. 
Guidance from UK economic and social research council applies 
to sharing qualitative data generally, but qualitative research 
in trials faces additional challenges, including the need to incor-
porate the necessary information and consent into already 
complex recruitment processes, with the additional sensitive 
nature of health-related data. Consequently, investigators lack 
proper guidance on how to comply with data sharing guidelines 
in a way that provides adequate anonymity protections (Tsai 
et al., 2016).
To this end, the aim of the project is to explore whether and 
how trial teams share qualitative data collected as part of the 
design, conduct or delivery of clinical trials. This project will 
provide the foundation for further methodological work and 
the future production of guidance by exploring potential 




Study design. This study will employ a qualitative descrip-
tive approach using thematic analysis of data (Braun & Clarke, 
2006). This approach explores general beliefs and views 
that expose the experiences described by target populations 
(Al Dandan et al., 2019). The perspectives and beliefs of par-
ticipants will be gathered using semi-structured focus group 
interviews via Zoom. The interview guide and all participant 
documents can be found as extended data (Houghton et al., 
2021).
Research team roles and prior experience. The research team 
was established through the Health Research Board- Trials 
Methodology Research Network (HRB-TMRN) and MRC-
NIHR Trials Methodology Research Partnership (TMRP) 
with researchers who share a common interest in qualitative data 
sharing in trials. Participants will be informed that the research 
is funded by the HRB- TMRN in collaboration with the MRC-
NIHR TMRP and the purpose of the study is clearly stated in 
the participant information leaflets (Houghton et al., 2021). 
All focus groups will be moderated and analysed by CH, LB 
and MD with assistance from MMC. CH, LB and MD have 
extensive experience in qualitative methodologies, qualitative 
evidence synthesis and qualitative data analysis. KG, NR and 
JW will provide methodological expertise and advise on how 
to recruit qualitative researchers in trials in the UK. CG will 
advise on existing guidance for data sharing in clinical trials 
and implications for qualitative data. ET has expertise in health 
research transparency and trial methodology and will provide 
input on all aspects of the project. KMS will provide guidance 
and support in the scoping activities to identify existing prac-
tices in trials. MS will provide advice on how best to access the 
UK trial community and will assist with the dissemination 
of the project findings. VB will advise on the development 
of the focus group interview guide for trial participants and 
will advise on recruitment for the focus group interview.
Sampling and recruitment. We will use a maximum variation 
approach to sampling to capture the views and experiences of 
different stakeholder groups across the UK and Ireland (Patton 
et al., 2008). We will conduct four focus groups of 6–8 key 
stakeholders each, from the UK and Ireland to explore their 
perspectives of qualitative data sharing in clinical trials. This will 
equal approximately 32 interviewees. The sample size for this 
study will follow guidance from Vasileiou et al. (2018) regard-
ing ‘data adequacy’, whereby we aim to have sufficient data 
for meaningful analysis capturing the perspectives of those 
          Amendments from Version 1
The protocol has been revised and improved following the 
constructive feedback from both peer reviewers. We have 
explained why participants should no longer be enrolled in a 
clinical trial to be eligible to participate in our focus groups. We 
have explained in more detail in the rigour section about how 
this project will control for bias. We have made other minor 
corrections and clarifications to the manuscript, in particular with 
regard to the coding and data analysis process. A more detailed 
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involved in qualitative research in clinical trials. In the context 
of this study, “data adequacy” appears more suitable than “data 
saturation” in the process of decision-making regarding 
sample sizes, given that the concept of data saturation is often 
poorly defined within qualitative studies (Sebele-Mpofu, 
2020). Separate focus group interviews will be conducted with 
members of each stakeholder group: trial managers, clinical 
trialists, qualitative researchers, members of research fund-
ing bodies and trial participants who have been involved in 
qualitative research.
The aim is to recruit participants who have had experience of 
qualitative data in clinical trials either as researchers, participants 
in trials or as funders reviewing grant application for clinical 
trials. We will recruit participants by contacting the UK Clinical 
Research Collaboration (UKCRC), Irish Clinical Research Facili-
ties (CRF) and through Health Research Board Trials Meth-
odology Research Network (HRB TMRN) and MRC-NIHR 
TMRP networks. We will ask them to circulate a recruitment 
email through their respective mailing lists and social media 
channels.
Once prospective participants express an interest in engaging 
with the study, they will be sent the participation information 
leaflet (see extended data) and will be required to complete 
an online consent form prior to their focus group (see 
extended data). Participants will be informed of the interview 
procedures and the recordings at least one week in advance 
of the research study. Participants will be provided with 
contact information for the research assistant (MMC) if they 
have any questions in advance, and it will be emphasised 
that consent in the research study is completely voluntary. 
Informed consent will be obtained prior to any data collection. 
Participants will also be required to consent to the use of record-
ings. Participation in focus groups will only commence once 
informed consent from all participants is received. Due to 
the minimally invasive nature of this study, as well as the famili-
arity with participants regarding research ethics and the research 
process, it is not anticipated that the study will cause any dis-
comfort or distress. It is also not anticipated that the study will 
causes any discomfort or distress as participants can withdraw 
at any stage of the focus group. However, if participants do 
become distressed during the course of the interviews, a distress 
protocol (see extended data) will be implemented by the inter-
viewers. While participants can withdraw at any point during the 
focus group, upon focus group completion it will not be 
possible to withdraw individuals due to the group format of the 
recording.
Inclusion criteria:
•     Aged 18 years or over
•     Any of the following:
•     Trial managers, clinical trialists, and qualitative research-
ers who have experience of qualitative research in 
clinical trials.
•     People working with trial funding agencies who have 
experience of reviewing grant applications for clinical 
trials with qualitative components.
•     People who have participated in a completed clini-
cal trial where data has been collected using qualitative 
methods.
Exclusion criteria:
•     Individuals under 18 years of age
•     Individuals with impaired capacity to consent 
independently
•     Individuals who are unable to understand or speak in 
English
•     Individuals currently still enrolled in a clinical trial as we 
want to capture the perceptions of those who can reflect 
on the full experience of trial participation. We also do not 
want to impose during their trial participation by adding 
additional research burden.
Data collection. Focus groups are a valuable method of data 
collection in qualitative research (Tausch & Menold, 2016). 
In comparison to individual interviews, which aim to explore 
individual attitudes, beliefs and feelings, focus groups elicit a 
multiplicity of views and use the process of interactions between 
participants to generate additional ideas and clarifications 
(George, 2013). Focus groups enable researchers to obtain a 
large amount of information within a short period of time.
This study will employ online methods of data collection as 
face-to-face contact is not possible due to current coronavi-
rus disease 2019 (COVID-19) restrictions, and virtual focus 
groups offer the opportunity to bring people together who are 
not geographically co-located. Focus group interviews will 
be conducted virtually using a secure Zoom video conferenc-
ing account and will be audio-visually recorded. In addition, 
field notes will be taken during the focus groups as they main-
tain contextual details and non-verbal expressions for data 
analysis and interpretation (Houghton et al., 2013; Tong et al., 
2007). Focus groups are expected to be one-off, and approxi-
mately one hour in duration. Participants will be made aware 
that focus group data cannot be withdrawn once the interview is 
finished but they do not have to answer particular questions 
if not comfortable doing so. 
We have developed a semi-structured interview guide (see 
extended data), that explores perspectives of sharing qualitative 
data, potential benefits and challenges of same, and recommen-
dations for what guidance is needed to support those involved in 
sharing qualitative data. A semi-structured topic guide con-
sists of open-ended questions and will help the researcher to 
remain flexible by adapting questions and elaborating on ideas 
(Willig, 2013). This method will help generate rich data as it 
allows participants to build on one another’s statements and 
comments (Guest et al., 2013; Tong et al., 2007).
Data protection. As focus group data will be collected through 
online methods, procedures for data collection and process-
ing will follow the six principles of the European (GDPR), 
and the Irish Data Protection Act, 2018. For focus groups, 
participants are asked to comply with confidentiality within 
the group and will sign consent to this prior to commencing 
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the group discussion. Online focus groups will be conducted 
via a secure Zoom account. Online focus groups will be 
moderated by a member of the research team and will be 
recorded.
When transcription is completed, audio visual recordings will 
be destroyed and only the anonymised transcripts with the pseu-
donyms will be retained. In accordance with NUIG Policy, 
transcripts, field notes and documents will be retained for a 
minimum of seven years. In accordance with GDPR 2018 and 
NUIG Personal Data Security Schedule (PDSS), electronic 
records will be held on the NUI Galway One Drive server 
accessed through a password protected, encrypted laptop belong-
ing to the lead researcher. All responses will remain confidential 
and individual names will not be directly linked to indi-
vidual responses at any time during or after the study. All 
interviewee responses will be pseudonymised prior to reporting 
of the results. Pseudonymised findings may be shared with 
members of the wider project research team to assist with 
and/or inform data analysis; however, all identifiable information 
will be removed and individual responses will not be reported. 
Only members of the research team based in NUIG will have 
access to the raw data collected, it will not be shared with anyone 
else, though a professional transcription company will be 
employed under strict data confidentiality agreements to 
transcribe the interviews.
Topic guides. The interview topic guide and questions were 
developed by members of the research team by reviewing 
existing literature regarding the sharing of qualitative data in 
clinical trials. The interview questions were based on the prin-
ciples of developing semi-structured interviews in qualitative 
research and therefore intended as a broad guide. CH, LB 
and MD, who will conduct the focus groups, are experienced 
qualitative researchers and are comfortable with participant 
driven conversations. Additional probes will be used to explore 
certain areas of interest in more depth. The interview guides 
for each stakeholder group are available as extended data.
Data analysis. Data from focus groups will be analysed using 
thematic analysis (Braun & Clarke, 2006). Thematic analysis 
is an inductive approach to analysis, going beyond description 
into interpretation and linked to telling a coherent story about 
what is going on in the data (Clarke & Braun, 2018, p106). 
Thematic analysis will be carried out in line with the six key 
steps outlined by Braun and Clarke.
Step one: Familiarisation. The first step involves the 
researcher(s) becoming familiar with and engaging with the 
data by reading and re -reading transcripts.
Step two: Coding. This step begins once the researcher is famil-
iar with the data and involves generating initial codes across 
the data set.
Step three: Generating themes. Searching for themes will 
begin and visualising how different codes may combine to form 
an overarching theme commences.
Step four: Reviewing themes. Step four will involve review-
ing potential themes and will require questioning the bounda-
ries of and judging whether there is sufficient data to support 
each theme.
Step five: Defining and naming themes. Clear definitions 
and names will be established for each theme in this stage.
Step six: Writing up. This step involves producing the final 
report which is achieved by weaving together the themes in a 
logical and meaningful manner (Braun & Clarke, 2006).
Work package 2
Study design. This study will also employ a documentary analy-
sis of current (i.e. past 5 years) consent procedures for qualitative 
data collected as part of the conduct of clinical trials.
Data collection. We will contact trials managers and individual 
researchers involved in using qualitative data in trials and by 
contacting UKCRC, Irish Clinical Research Facilities (CRF), 
and through HRB TMRN and MRC-NIHR TMRP networks, 
we aim to explore current consent procedures for qualita-
tive data collected as part of the conduct of trials. We will 
develop a tailored data extraction form to extract data such as 
whether specific clauses for data sharing are included in the 
consent form. CH and MMC will review documents includ-
ing participant information leaflets and consent forms for the 
qualitative components in trials. We aim to capture consent 
procedures for approximately forty qualitative studies in trials.
Data analysis. We will use a tailored extraction form to extract 
data such as whether specific clauses for data sharing are included 
in the consent form. We will use content analysis to analyse 
whether and how consent is being obtained for qualitative data 
sharing (Elo & Kyngäs, 2008). Content analysis is a valuable 
method for analysing qualitative material and seeks to analyse 
data in view of the meanings someone attributes to them 
(Krippendorff, 2018). This will provide baseline informa-
tion on the prevalence of qualitative data sharing as well as the 
strategies being employed to do so. We will also analyse the 
purpose for which sharing of qualitative data is being requested, 
for example, within a group of trials, or for broader open 
science purposes.
The findings from both the focus group interviews and the 
documentary analysis of current consent procedures, will provide 
an insight into what is happening currently, the challenges and 
opportunities, and what is needed in terms of best practice 
guideline development for sharing qualitative data in trials.
Rigour. The research team will agree the coding and theme 
development from the qualitative phase to ensure the data is 
represented sufficiently in the developed themes which will 
minimise researcher bias. The analysis will be conducted by 
CH, supported by MD and LB and managed within QSR Nvivo 
version 12 to provide a transparent audit trail of the deci-
sions made through the analysis (Houghton et al., 2013). 
The coding will be an iterative process, and CH along with other 
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members of the research team including MD and LB will move 
between the transcripts and the nodes created. MD and LB will 
also offer feedback on interpretations of the data and encour-
age reflexivity. We will utilise the queries tools in Nvivo to 
enable us to ask ‘questions’ of the analysis to minimise any 
potential researcher bias (Houghton et al., 2013). A codebook 
will be created within QSR NVivo to exhibit the reliability and 
credibility of our findings.
Ethics approval. We have received ethical approval from 
NUI Galway Research Ethics Committee (REF:2021.01.009). 
It is important to note that the raw transcript materials gener-
ated during the study will be confidential. Only members of the 
 research team will have access to the raw transcript materials. 
Dissemination. The findings of both work packages will be 
presented to the TMRP Trial Conduct and Health Informatics 
working groups in a format of their preference, for example as 
part of the MRC-NIHR TMRP and the HRB-TMRN webi-
nar series. We will also use the study findings to inform a 
consensus building workshop, following project completion, 
to identify model data sharing documents to act as an interim 
source of good practice guidance pending development of 
comprehensive guidance, and to make these available for 
the trials community via MRC-NIHR TMRP Trial Conduct 
Qualitative Research in trials (QRiT) target group. The consensus 
process will involve forming an advisory panel from the QRiT 
target group, thus providing an opportunity for members of this 
group to help drive this agenda and contribute their expertise 
in this area. This will also highlight the MRC-NIHR, TMRP/
HRB-TMRN work in this area, facilitating networking for 
subsequent activity. We will use the findings to inform further 
grant applications to develop more cohesive best practice 
recommendations guidance on sharing qualitative data collected 
in clinical trials. We will develop a plain language summary and 
disseminate the findings through social media and websites such 
as MRC-NIHR TMRP, HRB–TMRN and Qualitative research 
in Trials Centre (QUESTS). 
Study Status. Recruitment for this study commenced in March 
2021.
Conclusion
This study will provide insight into the existing practice of shar-
ing of qualitative data in clinical trials and the current issues and 
opportunities, to help shape future research and development 
of guidance to encourage maximum learning to be gained 
from this valuable data.
Data availability
Underlying data
No data is associated with this article.
Extended data
Open Science Framework: Qualitative data sharing practices 
in clinical trials in the UK and Ireland: Towards the production 
of good practice guidance. https://doi.org/10.17605/OSF.IO/
BKC8D. (Houghton et al., 2021).
This study contains the following extended data:
•     Appendix 1: Recruitment emails
•     Appendix 2: Participant Information leaflets
•     Appendix 3: Informed consent form
•     Appendix 4: Distress Protocol
•     Appendix 5: Focus group Interview guide
Data are available under the terms of the https://creative 
commons.org/licenses/by/4.0/legalcode. (CC-BY 4.0)
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Spencer Phillips Hey  
Center for Bioethics, Harvard Medical School, Boston, MA, USA 
Data sharing is an increasingly important issue for trials, particularly as the volume of trials -- and 
therefore the volume of trial data potentially available for secondary use -- continues to grow at 
such an incredible pace. While I have encountered several studies examining the logistical and 
ethical challenges associated with sharing patient-level, quantitative data, this protocol is the first 
I’ve seen describing a plan to explore issues around sharing of qualitative data. I thus found this 
protocol paper to be a welcome development, and the proposed research strikes me as a valuable 
contribution aimed at addressing an important gap in knowledge. 
 
However, similar to the previous reviewer, I do think there are some sections in this paper that 
need greater discussion and clarification. 
 
Foremost among these (for me) is the subsection on Rigour and the thematic analysis: I think 
much more should be said about how this project will control for bias – and in particular, the 
possibility that the themes identified will reflect (or be strongly biased towards) the interest, 
concerns, or assumptions of the research team. For example, I note that the focus group interview 
guide (Appendix 5) includes prompts about potential benefits (question 4), challenges (question 5), 
and recommendations (question 6) for sharing qualitative data, but it does not include a question 
about potential harms. Perhaps “challenges” is intended to encompass the potential for harm, but 
it is not clear to me that it does and I would not interpret the word in that way. I’d thus strongly 
suggest adding a dedicated prompt about potential harms (e.g., to privacy or dignity) and being 
clear to distinguish this from the prompt about logistical/technical/social “challenges”. 
 
The one sentence in the protocol on this potential for bias currently reads: “The research team will 
agree [to?] the coding and theme development from the qualitative phase to ensure the data is 
represented sufficiently in the developed themes which will minimise researcher bias.” I suspect 
there may be a grammatical error here, which I’ve tried to correct with my bracketed addition. But 
even the corrected sentence doesn’t really tell me much about what will be done to avoid bias. In 
fact, since my concern is that the results may be biased toward the research team’s interest, this 
sentence would only seem to confirm that this bias is "baked in" to the study plan. 
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Following on this, I worry also about the potential for bias arising from the sample size and 
sampling strategy. 32 interviewees strikes me as a rather small number of participants, 
particularly if this 32 will be a heterogeneous mix of five different stakeholders (trial managers, 
clinical trialists, qualitative researchers, members of research funding bodies, and trial 
participants who have been involved in qualitative research). I am not an expert in qualitative 
research, so this concern may be misplaced, but even looking up the methodological references 
provided in the protocol suggests that 6 interviews per group is on the low side to achieve “data 
adequacy” (e.g., Vasileiou et al. 2018). (Although I confess I found that Vasileiou paper somewhat 
difficult to decipher as a methodological guidance document, since it is itself, a thematic analysis 
of qualitative research methods...) 
 
Similarly for the recruitment strategy: Leveraging research networks in the UK and Ireland makes 
complete sense from a pragmatic perspective. However, this strategy seems likely to miss 
individuals who may have had negative experiences with qualitative data sharing (e.g., because 
they may have specifically tried to disconnect themselves from established research institutions), 
and I think it would critical to try and capture at least some of this perspective. 
 
But to be clear: None of this makes me think that this paper should not be approved. I believe the 
overarching questions are important and the gap in knowledge is real. I also believe the research 
team has likely thought much about all the issues I've raised. I think the manuscript could thus be 
improved  by sharing more of that thinking, e.g., expanding the discussion of the potential for bias 
and steps taken to ensure (as much as possible) that critical perspectives (i.e., valid arguments 
from stakeholders who think that qualitative data should not be shared) are represented.
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Overall I found this protocol paper interesting and well thought out. The rationale and methods 
are clearly stated. The research (and guidance) gap around sharing of qualitative trial data and the 
contribution that this research will make, and how the results will be disseminated are all available 
in this protocol. However, there are several areas of clarification that would be useful for readers 
that the authors may like to expand upon in order that this research could be truly reproducible. I 
have listed these below for the authors’ consideration. 
 
Work package 1: 
It might be useful to expand the point about the development of the interview topic guide. The 
authors mention that they reviewed existing literature regarding sharing of qualitative data in 
clinical trials, but did they model any of their questions on those in the existing literature, with 
modifications? If so, which existing literature was used? The authors could refer briefly to the 
papers here. 
 
I understand the exclusion criteria, but it might be useful for the authors to state explicitly why 
participants should no longer be taking part in a clinical trial. 
 
Can the authors expand upon/confirm that the coding in NVivo was data driven or theory driven? 
The authors don’t mention using a framework to code, but can they confirm that they did not and 
that the coding was instinctive? 
 
It might be useful for the authors to state which researcher will conduct the coding, or whether 
more than one researcher will do this. The authors do make clear that there will be team 
consensus on codes and themes afterwards to reduce bias but will there be consensus during 
coding? 
 
Work package 2:  
Could the tailored extraction form be provided in extended data?
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